This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

BYRD S. LEAVELL, M.D.

AMA Arch Intern Med. 1954;94(5):801-805.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SICKLE cell anemia was described first by Herrick in 1910.¹ Since then, surveys of Negroes in the United States have revealed the incidence of the symptomless sickle cell trait to be about 9% and incidence of sickle cell anemia to be about 2.25 per thousand.² In the past decade sickle cell anemia has been the subject of many studies, which have contributed greatly to our understanding of many of the abnormalities that occur in the disease. Conclusions drawn from these studies form the basis for our current ideas of the pathogenesis of the disease. Since our present therapy is directed toward this aspect of the disease, the pathogenesis of sickle cell anemia will be reviewed briefly before treatment is discussed.

It now seems well established that the sickling phenomenon is due to a gene which produces sickle cell anemia when it is present in the homozygous state and . . . [Full Text PDF of this Article]

Author Affiliations
CHARLOTTESVILLE, VA.

From the Department of Internal Medicine, School of Medicine, University of Virginia Hospital; Professor of Internal Medicine.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?